/
ABVC
$1.00+$0.02 (+2.03%)prev close
Change$-25.10
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$26.1M
27M shares
52-week range
$0.71 – $3.40
11% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
ABVC BioPharma, Inc. Common Stock
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
www.abvcpharma.com- Employees
- 19
- IPO / List date
- Nov 9, 2004
- HQ
- FREMONT, CA
Held by traders on TradeandTell
No one on the platform currently holds ABVC.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 95,100 | $92.3K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2023-07-25 | 1-for-10reverse |
| 2019-05-08 | 1-for-18reverse |
| 2016-04-11 | 3.141-for-1 |
| 2010-12-28 | 5-for-1 |
| 2007-06-19 | 2.573255-for-1 |
Recent trades on TradeandTell
No one on the platform has traded ABVC yet.
